I don’t believe Resapp mismanaged the previous submission. The...

I don’t believe Resapp mismanaged the previous submission. The excuse for refusal from FDA was that the risks outweigh the benefits. And the data compared Resapp to doctors who couldn’t agree on what day of the week it was.
I believe the company shouldn’t waste anymore time and money on submissions to the FDA. They should continue what they are doing. Eventually the US will come to Resapp. If there is another refusal it will be a disaster for shareholders, like last time. The company are doing a great job with uptake outside the US.
My thoughts only.